Diagnosis of Mild Cognitive Impairment Due to Alzheimer’s Disease with Transcranial Magnetic Stimulation

Discrimination of atypical parkinsonisms with transcranial magnetic stimulation

(2018) Alberto Benussi et al.   Brain Stimulation

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

(2017) Giovanni B Frisoni et al.   LANCET NEUROLOGY

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

(2017) Valentina Garibotto et al.   NEUROBIOLOGY OF AGING

Clinical validity of presynaptic dopaminergic imaging with  123 I-ioflupane and noradrenergic imaging with 123 I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework

(2017) Ida Sonni et al.   NEUROBIOLOGY OF AGING

Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework

(2017) Niklas Mattsson et al.   NEUROBIOLOGY OF AGING

Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia

(2017) Alberto Benussi et al.   NEUROLOGY

Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia

(2016) Alberto Benussi et al.   ANNALS OF NEUROLOGY

Reversal of LTP-Like Cortical Plasticity in Alzheimer’s Disease Patients with Tau-Related Faster Clinical Progression

(2016) Giacomo Koch et al.   JOURNAL OF ALZHEIMERS DISEASE

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment

(2016) Marina Boccardi et al.   JAMA Neurology

Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee

(2015) P.M. Rossini et al.   CLINICAL NEUROPHYSIOLOGY

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions

(2015) Sandrine Andrieu et al.   LANCET NEUROLOGY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia

(2014) Barbara Borroni et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Imaging markers for Alzheimer disease: Which vs how

(2013) G. B. Frisoni et al.   NEUROLOGY

Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease

(2013) Kaj Blennow et al.   NEUROPSYCHOPHARMACOLOGY

Relation of neuropathology to cognition in persons without cognitive impairment

(2012) David A. Bennett et al.   ANNALS OF NEUROLOGY

Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients

(2012) Alessandro Martorana et al.   JOURNAL OF NEURAL TRANSMISSION

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

(2012) Christopher M Clark et al.   LANCET NEUROLOGY

Mild cognitive impairment: pathology and mechanisms

(2011) Elliott J. Mufson et al.   ACTA NEUROPATHOLOGICA

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Motor Neuron dysfunction in frontotemporal dementia

(2011) James R. Burrell et al.   BRAIN

The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study

(2010) Stefan J. Teipel et al.   HUMAN BRAIN MAPPING

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

(2008) Clifford R. Jack et al.   BRAIN

Abnormal short latency afferent inhibition in early Alzheimer’s disease: a transcranial magnetic demonstration

(2008) Raffaele Nardone et al.   JOURNAL OF NEURAL TRANSMISSION